Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Johnson & Johnson plans joint TB drug research with CSIR

US healthcare major Johnson & Johnson has joined hands with the Institute of Microbial Technology (IMTECH), Chandigarh to develop new drugs for tuberculosis (TB), a disease that kills thousands of people in India every year.

 
 
India has always had a patchy track record when it comes to public private partnerships (PPP) in healthcare.
A recent update by the market intelligence firm AIOCD-AWACS indicates that the inventory of medicines at the trade level was holding steady as on June 21.
The GST tax rates for pharamceuticals does not seem to upset the industry. Question remains, however, as to how smooth the transition will be.
Advertisement